OUR STUDY IS NOW CLOSED, BUT IF YOU HAVE SUDDEN HEARING LOSS IN ONE EAR YOU SHOULD SEEK CARE ASAP AT YOUR LOCAL OTOLARYNGOLOGY / AUDIOLOGY OFFICE

_________________________

What is sudden sensorineural hearing loss?

Study overview

What is intratympanic steroid therapy? (Flash video)

What are the entry criteria?

What if I have limited or no medical insurance?

___________________________

Eight centers around the U.S. initially participated in this clinical study, and this was expanded to eight more centers in the U.S. and Canada.

We are analyzing the data from our five year study and the first publication of these results will take place in the next 1-2 years.

__________________________

Johns Hopkins Hospital in Baltimore, Maryland, recruited the first patient for the SSNHL trial on Dec 22, 2004. We have recently completed the recruitment of patients for our study.

___________________________

information for SSNHL investigators

___________________________

if you are UNABLE to contact a specialist and if you have SSNHL within 2 weeks of the symptoms, you can also contact us at:

hearingresearch@gmail.com


Sudden Sensorineural Hearing Loss (SSNHL) Multicenter Treatment Trial

ENTRY CRITERIA

1. Adult men or women (18 years and older) with a history of normal hearing in both ears prior to symptoms

2. Sudden hearing loss in one ear (muffled or absent hearing that occured within a 1 to 3 day period)

3. Symptoms of hearing loss must be within the past 1-14 days - patients that have had hearing loss for longer than several weeks are not eligible.

3. Audiogram - thresholds of 50 dB PTA or worse on the affected ear. The other ear should have normal to near-normal hearing.

4. No more than 10 days of treatment with oral steroids - ideally, we need patients who have received no therapy for this study.

We encourage referring physicians to not begin any treatment on patients who are sent to one of the study centers.

Any patients who do not fulfill our study criteria will be started on appropriate therapy and returned to the referring specialist.

By recruiting patients who have received no treatment prior to enrollment in our study, we can ensure that we collect the most accurate data about how patients respond to each of the randomized treatment arms.






   
image